9UW-21997-15943
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 282 / NC
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
- 2021-03-31
-
2021-04-05
Dose 2 — Pfizer-BioNTech
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, HeadacheAdult check-in
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-11
- 2021-04-12
- 2021-04-19
- 2021-04-28
-
2021-05-03
Survey response — day 28, dose 2MedDRA: Diarrhoea, Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: Vomiting and diarrhea on 5/2 for 12 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech |
Free text
Release 8 — day 28, dose 2
Symptoms: Vomiting and diarrhea on 5/2 for 12 hours
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release